Natural History of Type 1 Interferonopathies: Insights From a European Cohort | MicrobiomeTrials← Back to trialsNCT07040774
Natural History of Type 1 Interferonopathies: Insights From a European Cohort
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-10-01Est. Completion: 2045-10
Enrollment target: 500 participants Locations- Medical University Innsbruck, Innsbruck, Austria
- Antwerp University Hospital, Antwerp, Belgium
- Children's Hospital Zagreb, Zagreb, Croatia
- Motol University Hospital, Prague, Czechia
- CHU d'Angers, Angers, France
- Hôpital de Mercy - CHR Metz Thionville, Ars-Laquenexy, France
- CHU de Besançon, Besançon, France
- CHU de Bordeaux, Bordeaux, France
- CHU Morvan, Brest, France
- Hôpital Femme Mère Enfant - HCL, Bron, France
- CHU de Dijon, Dijon, France
- Hôpitaux Nord Ouest Villefranche, Gleizé, France
- Hôpital Bicêtre, Le Kremlin-Bicêtre, France
- Hôpital Claude Huriez, CHU de Lille, Lille, France
- APHM Hôpitaux de Marseille, Marseille, France
- CHU de Montpellier, Montpellier, France
- CHRU Nancy, Nancy, France
- CHU de Nantes, Nantes, France
- CH Agen-Nérac, Nérac, France
- Hôpital de l'Archet, Nice, France
- Hôpital Armand Trousseau, Paris, France
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative NeoplasmAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia, Myelodysplasia-RelatedMyelodysplastic Syndrome
Hôpital Bichat, Paris, FranceHôpital Robert Debré, Paris, FranceHôpital des Enfants - CHU de Toulouse, Toulouse, FranceHôpital Necker Enfants Malades, Paris, Île-de-France Region, FranceUniversity of Tübingen, Tübingen, GermanyMeyer Children's Hospital IRCCS, Florence, ItalyHospital Universitari Vall d'Hebron, Barcelona, SpainHospital Universitario Son Espases, Palma de Mallorca, SpainKarolinska University Hospital, Stockholm, SwedenHacettepe İhsan Doğramacı Children's Hospital, Ankara, Turkey (Türkiye)Leeds Teaching Hospitals NHS Trust, Leeds, United KingdomThis MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific lab…
Birmingham, United StatesEst. completion May 15, 2029
Undiagnosed DiseasesRare Diseases
Background:
Genetics research over the past 20 years has helped researchers find the causes of many diseases. More powe…
Moka, MauritiusEst. completion Aug 21, 2034